PALO ALTO, Calif. & PARIS--(BUSINESS WIRE)--May 31, 2006--Agilent Technologies Inc. (NYSE:A - News) and ExonHit Therapeutics (Euronext:ALEHT) announced today that they have entered into a marketing alliance in which Agilent will market and sell nine different ExonHit human and mouse SpliceArrays as commercial products. These SpliceArrays include GPCR, Ion Channel, nuclear receptors and apoptosis pathways.
